MedTrace Logo

Transition Care for FEP

NCT07713849 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2026-07-20

No results posted yet for this study

Summary

This study is testing a new approach to help people with first episode psychosis transition successfully from the hospital to outpatient mental health care. Many patients lose contact with services after they leave the hospital, which can lead to worse outcomes. The investigators have developed a Transition Care Team (TCT) that works with patients while they are in the hospital and continues to support them after discharge. The team provides therapy, case management, and coordination with community programs that offer ongoing care. The main goal of the study is to find out if this new program increases the number of patients who successfully begin outpatient treatment after hospitalization, compared to usual care. The investigators will also look at whether the program improves symptoms, functioning, and overall well-being.

Conditions

  • Schizoaffective Disorders
  • Bipolar Disorder With Psychotic Features
  • Schizophrenia Disorders
  • Major Depressive Disorder With Psychotic Features
  • Psychosis NOS

Interventions

BEHAVIORAL

Transition Care Team

The novel intervention is the Transition Care Team (TCT), a multidisciplinary clinical support model designed to improve continuity of care for individuals experiencing a first episode of psychosis. The TCT provides short-term post-discharge services, including psychoeducation, case management, peer support, and coordination with outpatient programs until participants are established in Coordinated Specialty Care (CSC). This differs from standard care, where patients typically receive discharge referrals without structured follow-up. The intervention itself uses evidence-based clinical practices but applies them in a new, transitional format for this population, which is not currently part of standard inpatient-to-outpatient care at UChicago or Ingalls.

Sponsors & Collaborators

Principal Investigators

  • Molly Erickson, PhD · University of Chicago

  • Carolyn Shima, PhD · University of Chicago

  • Sarah Keedy, PhD · University of Chicago

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-05-06
Primary Completion
2028-05-06
Completion
2029-05-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07713849 on ClinicalTrials.gov